Background: The interaction of microRNA with Chinese herbal medicines is a promising therapeutic approach for prevention of cervical cancer.
Methods: Western blotting or qRT-PCR were carried out to identify the expression of and miR-638. A tetrandrine (TET) cell model was used to explore the effects of miR-638 and its target gene using CCK-8, transwell, wound healing, and western blot assays. Furthermore, luciferase activity assay was conducted to measure the interaction among TET, and miR-638.
Results: Under TET treatment, Hela and SiHa cells exhibited repressed cell viability, migration, invasion, and epithelial-mesenchymal transition (EMT), and these effects were further enhanced by high expression of miR-638. In contrast, expression was low in TET-treated cells and had an opposite effect to that of miR-638.
Conclusion: We highlighted that miR-638 suppresses cervical cancer progression by inhibiting under tetrandrine treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.14670/HH-18-657 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
miR-638 suppresses cervical cancer progression by inhibiting under the treatment of Tetrandrine.
Histol Histopathol
April 2024
Department of Gynecology, First Clinical College, Hubei University of Chinese Medicine, Wuhan, Hubei, PR China.
Background: The interaction of microRNA with Chinese herbal medicines is a promising therapeutic approach for prevention of cervical cancer.
Methods: Western blotting or qRT-PCR were carried out to identify the expression of and miR-638. A tetrandrine (TET) cell model was used to explore the effects of miR-638 and its target gene using CCK-8, transwell, wound healing, and western blot assays.
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy.
Front Oncol
June 2023
Integrated translational Molecular Biology laboratory, Department of Rog Nidan and Vikriti vigyan (Pathology), All India Institute of Ayurveda (AIIA), New Delhi, India.
With a high mortality rate that accounts for millions of cancer-related deaths each year, breast cancer is the second most common malignancy in women. Chemotherapy has significant potential in the prevention and spreading of breast cancer; however, drug resistance often hinders therapy in breast cancer patients. The identification and the use of novel molecular biomarkers, which can predict response to chemotherapy, might lead to tailoring breast cancer treatment.
View Article and Find Full Text PDFHsa_circ_0008344 Promotes Glioma Tumor Progression and Angiogenesis Presumably by Regulating miR-638/SZRD1 Pathway.
Neurotox Res
June 2022
Department of Oncology, Changsha Central Hospital, No. 161, Shaoshan South Road, Changsha, Hunan, China.
Hsa_circRNA_0008344 (circ_0008344) is a new glioma-related circular RNA. Our study aims to explore its functions in glioma tumor progression. Real-time quantitative PCR and western blotting were used to detect RNA and protein abundances.
View Article and Find Full Text PDFmiR-638: A Promising Cancer Biomarker with Therapeutic Potential.
Curr Mol Med
April 2023
Department of Clinical Biochemistry and Medical Genetics, Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Background: There is an unmet need to improve the diagnosis of cancer with precise treatment strategies. Therefore, more powerful diagnostic, prognostic, and therapeutic biomarkers are needed to overcome tumor cells. microRNAs (miRNAs, miRs), as a class of small non-coding RNAs, play essential roles in cancer through the tumor-suppressive or oncogenic effects by post-transcriptional regulation of their targets.
View Article and Find Full Text PDFmiR-638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells.
Exp Ther Med
November 2021
Department of Pathology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Ovarian cancer is one of the most common gynecological diseases with high mortality rates. Previous studies have shown that microRNA (miR)-638 is associated with tumorigenesis. The present study aimed to assess the role and underlying mechanisms of miR-638 in ovarian cancer.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!